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Summary 
Nitric oxide (NO), a highly diffusible cellular mediator involved in a wide range of biological 
effects, has been indicated as one of the cytotoxic agents released by leukocytes to counteract 
malaria infection. On the other hand, NO has been implicated as a mediator of the neuropatho- 
logical symptoms of cerebral malaria.  In such circumstances NO production has been thought 
to be induced in host tissues by host-derived cytokines. Here we provide evidence for the first 
time that human red blood cells infected by Plasrnodiurafakiparura  (IRBC) synthesize NO. The 
synthesis of NO (measured as citrulline and nitrate production) appeared to be very high in 
comparison with human endothelial cells; no citrulline and nitrate production was detectable 
in noninfected red blood cells. The NO synthase (NOS) activity was very high in the lysate 
of IRBC (while not measurable in that of normal red blood cells) and was inhibited in a dose- 
dependent way by three different NOS inhibitors (l.-canavanine, NtLamino-t-arginine, and N G- 
nitro-t-arginine). NOS activity in P. fakiparura IRBC is Ca ++ independent, and the enzyme 
shows an apparent molecular mass <100 kD, suggesting that the parasite expresses an isoform 
different from those found in mammalian cells. IRBC release a soluble factor able to induce 
NOS in human endothelial cells. Such NOS-inducing activity is not tissue specific, is time and 
dose dependent, requires de novo protein synthesis, and is probably associated with a thermola- 
bile protein having a molecular mass >100 kD. Our data suggest that an increased NO synthesis 
in P. fakiparurn malaria can be directly elicited by soluble factor(s) released by the blood stages 
of the parasite,  without necessarily requiring the intervention of host cytokines. 
N 
itric oxide (NO) a is a short-lived free radical gas pro- 
duced by a wide variety of cell types, the best studied 
of which are vascular endothelial cells (1, 2), macrophages 
(3-5), and neurons (6). NO is generated by a class of nico- 
tinamide adenine dinucleotide phosphate (NADPH)-depen- 
1 Abbremations used in this paper, cNOS, constitutive nitric oxide synthase; 
DTT, dithiothreitol; eNOS, endothelial nitric oxide synthase; HUVEC, 
human umbilical vein endothelial cell; iNOS, inducible nitric oxide syn- 
thase;  IRBC,  infected  red  blood  cell;  t-NAA,  NG-amino-t-arginine; 
t-NNA, Nr-nitro-t-arginine; NADPH, nicotinamide adenine dinudeo- 
tide phosphate; NO,  nitric oxide; NOS,  nitric oxide synthase;  PNIF, 
Plasmodium-derived NOS-inducing factor; RBC, red blood cell; SNP, so- 
dium nitroprusside; Vmax, maximal rate. 
dent NO synthases  (NOS), which catalyze the conversion 
of L-arginine to L-citrulline and NO with a 1:1 stoichiometry 
(7, 8). At least three different isoenzymes have been charac- 
terized (9,  10): Two of them are constitutive and Ca + +/ 
calmodulin activated (endothelial and neuronal cNOS), and 
one is an inducible, Ca + +-independent iNOS  detected in 
macrophages. NO  synthesis occurs in response to a large 
number of stimuli such as cytokines, endotoxin, and Ca + +- 
mobilizing agonists.  NO displays manifold activities,  such 
as smooth musde relaxation, inhibition of platelet aggrega- 
tion and adhesion, and decrease of smooth muscle cell prolifer- 
ation (9,  11, 12). These events have been partly attributed 
to NO-mediated activation of a soluble guanylate cyclase (13), 
but NO interacts with other intracelhlar targets as an ADP- 
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tissues  as  glyceraldehyde-3-phosphate  dehydrogenase  (15). 
Glyceraldehyde-3-phosphate dehydrogenase impairment,  as 
well as inhibition of ribonucleotide reductase (16) and iron- 
and sulfur-containing  enzymes (17),  may account for NO- 
elicited cytotoxicity. 
NO has  been shown  to be involved in different aspects 
of Plasmodium fakiparum  malaria.  Serum levels of cytokines 
known to induce NO synthesis, such as TNF and II-,1, are 
increased in malaria patients (18), and TNF or Ibl injection 
into healthy mice considerably increases  NO generation (19, 
20). Killing of malaria parasites by the mouse immune system 
correlates with increased levels of nitrogen oxides in plasma 
(21, 22). NO or its derivatives inhibit  the in vitro growth 
of asexual blood stages of P. faki~rum  (23) and of exoerythro- 
cytic stages of P. berghei (24) and P. yoelii (25).  During schi- 
zogony in blood, the infectivity of P. vincleei petteri gameto- 
cytes was markedly reduced but could be restored by prior 
injection of an NOS inhibitor  (26).  NOS inhibitors reverse 
the inhibition of development of the hepatic stage ofP. yoelii 
induced by IL-6 and TNF (25).  The injection of irradiated 
malaria  sporozoites (27) or the exposure to mosquitoes in- 
fected with irradiated sporozoites (28) induces NO synthesis 
in mice hepatocytes, which is responsible for a liver refrac- 
tory status against reinfection. P. fakiparum-infected  human 
hepatocytes develop the ability to inhibit the growth of para- 
sites via induction of NO synthesis, which is potentiated by 
IFN-3' (29). Finally,  a link between NO production and ce- 
rebral  malaria  has  been  suggested.  During  infection,  NO 
released  by TNF-stimulated  vascular ceUs could diffuse to 
nearby neurons, thus interfering with neurotransmission and 
contributing  to neurological symptoms (18,  19). All of the 
results  mentioned  above point  to  the  following  scenario: 
During malaria infection, the enhanced synthesis of cytokines 
(TNF, Ibl, IFN-% IL-6, etc.) induces host cells (leukocytes, 
endothelium,  hepatocytes,  etc.)  to  produce NO,  and  NO 
reduces the growth and invasiveness  of parasites.  Excessive 
NO production may lead to negative side effects for the host, 
thus contributing  to malaria  complications. 
The  present  work  was  designed  to  study whether  the 
P. falciparum is able per se to synthesize NO and/or directly 
evoke NO production in human ceils.  Our results demon- 
strate that the infected human red blood cells (IRBC) pro- 
duce NO and release  a soluble factor that induces NOS in 
human endothelial cells, thus suggesting a new pathogenetic 
mode of parasite-host  interaction. 
Materials and Methods 
Reagents 
Medium  M-199 and trypsin/EDTA  were from GIBCO-BRL 
(Paisley, Scotland); FCS was from Irvine Scientific (Santa Ana, CA); 
plastic for cell culture was from Costar Italia (Milan, Italy); col- 
lagenase and ionomycin were provided by Boehringer Mannheim 
(Mannheim,  Germany);  the  cationic  exchange  resin Dowex 
AG50WX-8, N-(1-naphthyl) ethylenediamine dihydrochloride, and 
sulfanilamide were from Aldrich Italia (Milan, Italy); and L-[2,3,4,5- 
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3H]arginine monohydrochloride  (54-62  Ci/mmol),  t-[1-14C]or  - 
nithine  (58 mCi/mmol),  and cGMP radioimmunoassay kit were 
from Amersham International (Little Chalfont, UK). RPMI 1640, 
Percoll, Giemsa, sodium nitropmsside (SNP), trifluoperazine, W5, 
dithiothreitol  (DTT), EDTA, NADPH, flavin adenine dinucleo- 
tide, nitrate reductase (from Aspergillus), Hepes (sodium salt), Tris- 
HC1, urease (type  VII),  diacetylmonoxime  (2,3-buthanedione 
monoxime), thiosemicarbazide, t-arginine, Dt-citrulline, /~-nitro- 
t-arginine (t-NNA), N~-amino-t-arginine  (L-NAA), L-canavanine, 
3-isobuthyl-l-methylxanthine  (IBMX), N-benzoylarginine  ethyl- 
ester, and formamidine were from Sigma Chemical Co. (St. Louis, 
MO). Other reagents were from Merck (Bubendorf, Germany) and 
were of the highest  purity available. The composition  of Hepes 
buffer was as follows: 145 mM NaC1, 5 mM KC1, 1 mM MgSO4, 
10 mM Hepes (sodium salt), 10 mM glucose, and 1 mM CaC12, 
pH 7.4, at 37~  The composition of Hepes-Na/EDTA buffer was 
as follows: 20 mM Hepes-Na and 2 mM EDTA, pH 6. The com- 
position of Hepes/EDTA/DTT buffer was as follows: 20 mM Hepes, 
0.5 mM EDTA, and 1 mM DTT, pH 7.2. Ionomycin was dissolved 
at 1 mM in DMSO and stored at -20~  until use; SNP was freshly 
prepared by dissolving at 100 mM in buffered saline. The protein 
content of cell monolayers was assessed with the modified micro- 
Lowry method (kit from Sigma Chemical Co.). Mouse mAbs anti- 
human endothelial cNOS (eNOS) and anti-murine  macrophage 
iNOS directed against protein fragments of 179 amino acids (eNOS, 
W 1~176  --" L 1~) and 183 amino acids (iNOS, F  ~1 "" Ll144), respec- 
tively, were from Transduction Laboratories (Lexington, KY). Elec- 
trophoresis reagents were from Bio-Rad Laboratories (Hercules, CA). 
Cell Cultures 
Human  Umbilical Vein Endothelial Cells (HUVEC).  HUVEC 
were obtained by treating human umbilical cord veins with colla- 
genase  from  Clostridium histolyticum (Boehringer  Mannheim) 
(10 mg/ml  medium  199) cultured  in  75  cm  2 plastic  flasks in 
medium 199 containing 20% FCS and characterized as previously 
described (30). 
P.falciparum Parasites.  P.fakiparum parasites (strains FCK-3, D2, 
D6, W2, HBR3) were kept in culture in human red blood cells 
(RBC) (type 0 + or A +) suspended in growth medium  (KPMI 
1640 supplemented with 10% heat-inactivated human AB + plasma, 
32 mM NaHCO3, 25 mM Hepes, and 10 mM glucose, pH 7.4) 
as described previously (31). To obtain packed RBC, 1 ml of sus- 
pensions (1% hematocrit) of IRBC (10-20% parasitemia) or RBC 
was centrifuged at 1,000g for 10 min and washed twice with PBS. 
When it was necessary to eliminate the RBC cytosol, the RBC 
membrane was permeabilized by Sendai virus. This treatment results 
in the release of >95% of host cell cytosol and does not impair 
parasite viability (32). Red cell suspensions (1 ml, 1% hematocrit 
and 10-20% parasitemia) in wash medium (culture medium without 
human plasma and bicarbonate) were incubated with Sendai virions 
(20-50 #g protein/ml,  equivalent to 400-600  hemagglutination 
U) for 10 min at 37~  and centrifuged for 5 rain at 2,200 g (31). 
The supernatant, consisting of host cell cytosol, was removed, and 
the  pellet  containing  the parasites was  washed  twice in  wash 
medium, resuspended in 1 ml Hepes/EDTA/DTT,  and sonicated 
and diluted  (see below) for NOS measurement. 
Rodent Plasmodia.  P. yoelii nigeriensis (NIG strain), P. yoelii kil- 
licki (194 ZZK strain), P. yoelii yoelii (265 BY and 17 X strains), 
P.  vinckei petteri (279 BY strain), P.  vinckei vinckei (67  strain), 
P. chabaudi chabaudi (864 VD strain), P. chabaudi adami (887 KA 
strain), P. berghei (ANKA strain), and P. berghei (NK 65 strain) 
were maintained in the laboratory by cryopreservation, Male out- 
bred Swiss, C57BL/6, and CBA/Ca mice (18-20 g) (Iffa Credo, EArbresle, France) were infected by injecting intraperitoneally 0.2 ml 
of thawed parasitized blood diluted 1:2 with isotonic saline. When 
parasitemias (23.9  +  5.6%;  n  =  8) were patent,  1 ml of whole 
blood was withdrawn from the retroorbital sinus with a heparinized 
Pasteur pipette. RBC from control mice were withdrawn by the 
same procedure explained before. After removing plasma, platelets, 
and leukocytes by centrifugation, packed erythrocytes were frozen 
in liquid nitrogen and checked for NOS activity in triplicate after 
24 h. 
Measurement of NOS Activity in Cell Lysates 
Human or routine RBC and IRBC were resuspended in 1 ml 
Hepes/EDTA/DTT buffer and sonicated (two 12-s bursts on crushed 
ice); if necessary (falciparum IRBC), before the test, the hemoly- 
sate was further diluted 40-fold with the same buffer. HUVEC 
grown to confluence in 75-cm  2 flasks were detached by trypsin/ 
EDTA (0.05:0.02% vol/vol). Cells from 8-12 flasks were pooled, 
washed with PBS, and then resuspended in I ml of Hepes/EDTA/ 
DTT buffer and sonicated on ice with three 10-s bursts. In each 
test tube, the following reagents were added to 100 #1 cell lysate 
up to a final volume of 120 #1 and the indicated final concentra- 
tions: 2 mM NADPH, 1.5 mM CaCI2,  1-100 #M L-arginine, and 
2.5 #Ci t-[3H]arginine (0.4/xM) (33,  34). When indicated, NOS 
inhibitors were added to the other reagents. A blank was prepared 
by replacing the cell lysate with an equal volume of Hepes/EDTA/ 
DTT buffer. After a 15-min incubation at 37~  the reaction was 
stopped by adding 2 ml cold Hepes-Na/EDTA buffer. The whole 
reaction  mixture  was  applied  to  2-ml  columns  of  Dowex 
AG50WX-8 (Na § form) and eluted with 4 ml of water. The ra- 
dioactivity corresponding  to  [3H]citrulline  content  in  "~6.1  ml 
eluate was measured by liquid scintillation. In P. fakilmrum IRBC, 
NOS activity was expressed as picomoles citrulline produced/min 
per 107 lysed parasites; this calculation was based on the number 
of RBC (counted by a B~rker chamber), their parasitemia, and 
an average of I  trophozoite or 1.2 ring per IRBC; in HUVEC, 
NOS activity was expressed as picomoles citrulline produced/min 
per milligram cell  protein. 
Western Blots 
Human RBC, trophozoite IRBC, and HUVEC were directly 
solubilized in boiling Laemmli buffer, and proteins,  separated by 
SDS-PAGE  (8%),  were  transferred  to  nitrocellulose  sheets  and 
probed with an mAb anti-iNOS (1:500) or anti-eNOS (1:250) and 
detected by enhanced chemiluminescence  (Amersham International). 
Measurement of Citrulline Synthesis in Intact Human 
RBC and HUVEC 
Citrulline synthesis was measured by a radiometric method (de- 
tection of extraceilular concentration in short-term experiments) 
and by a colorimetric method (measurement of extracellular citrul- 
line  accumulation  during  long-term  incubations).  Radiometric 
citrulline detection in RBC was performed as a modification of 
previously described procedures (32-34).  RBC (2.5  x  107) were 
resuspended in 0.1  ml Hepes buffer containing  10/~Ci (1.6/zM) 
t-[3H]arginine. After incubation at 37~  for 15 min in the pres- 
ence of 2/zM  ionomycin or DMSO  (as a control),  the reaction 
was stopped by washing ceils with cold PBS containing 5 mM t-argi- 
nine and 4 mM EDTA. The samples were centrifuged at 12,000 g 
for  10  s,  and  50 #1  supernatant  was mixed with  2  ml Hepes- 
Na/EDTA buffer. The mixture was appIied to a Dowex column, 
and [3H]citrulline-related radioactivity was counted in the eluate, 
as indicated before. [3H]Citrulline synthesis in HUVEC was men- 
sured in a similar way, as previously described (35). Citrulline syn- 
thesis was expressed as picomoles citruiline produced/rain per 107 
parasites (IRBC) or picomoles citruUine produced/min per milli- 
gram cell protein (HUVEC). Colorimetric citruUine detection in 
the extracellular medium of RBC suspensions was performed ac- 
cording to Boyde and RahmatuUah (36). Briefly, after urease treat- 
ment (2 U/ml, 30 min, 37~  and deproteinization with 5% TCA 
and centrifugation, 0.1 ml supernatant was mixed with 3 ml chro- 
mogenic solution and boiled. After cooling, absorbance at 530 nm 
was measured.  Citrulline  synthesis was expressed as nanomoles 
citrulline produced/24 h per 107 parasites;  because of the different 
experimental conditions (1.26 mM extracellular L-arginine in the 
latter setting), these results cannot be superimposed on those ob- 
tained  by  the  radiometric  technique  (where  the  extraceilular 
t-arginine concentration was only 1.6/~M,  and much arginine is 
produced intracellularly during the digestion of host cell cytosol 
by the parasite). 
Measurement of Nitrite 
Nitrite production was measured by adding 0.15 ml of medium 
from human RBC, IRBC, and HUVEC cultures to 0.15  ml of 
Griess reagent (37), and, after 30 min of incubation at room tem- 
perature in the dark, absorbance at 540 nm was measured using 
a microplate reader. 
Measurement of Nitrate 
Since RPMI 1640-derived growth medium contains very high 
amounts of nitrate, we incubated RBC and IRBC (FCR-3 strain, 
ring stage) in the low-nitrate medium M-199 for 24 h. After this 
time,  during  which  parasitemia (13  _+  2.7%;  n  =  3)  did  not 
significantly change, nitrate production was measured by a kinetic 
assay using Aspergilhs nitrate reductase (38).  0.1  ml of extracel- 
lular medium was mixed with 0.2 ml of reaction mixture (final 
concentrations:  2.5  /iM  flavin  adenine  dinucleotide,  100  /~M 
NADPH, and 56 mM K2HPO4, pH 7.5),  and 18 mU of nitrate 
reductase was added.  The oxidation of NADPH was monitored 
in a microplate reader by following the change in absorbance at 
340 nm for 20 min (during this time the oxidation of NADPH 
was linear). The change in absorbance of fresh medium M-199 was 
taken as a blank. 
cGMP Determination 
Packed human RBC and IRBC (20 #1) were resuspended in 200 
#1 Hepes buffer containing 0.1 mM t-arginine and 0.2 mM IBMX; 
after 30 min incubation at 37~  in the presence or absence of 2 
/~M ionomycin and I mM SNP, samples were centrifuged at 12,000 g 
for 10 s, supernatant was discarded, and the pellet was resuspended 
in 50/~1 absolute ethanol. Solvent was evaporated by vacuum cen- 
trifugation, and the pellet was resuspended in 300/~1 Tris/EDTA 
buffer (50 mM Tris-HC1, 4 mM EDTA, pH 7.5);  after 10 rain of 
shaking, samples were centrifuged and 100 ~1 supernatant was used 
for cGMP measurement.  RBC cGMP content was measured by 
radioimmunoassay (39)  and expressed as picomoles/107 RBC. 
Effects of Drugs on Parasite Growth 
Synchronous parasite cultures at the ring stage were cultivated 
in  the presence of increasing drug concentrations  for 24  h,  and 
then [3H]hypoxanthine was added to a final concentration of 10 
/~Ci/ml. After an additional 24 h in culture, cells were harvested 
onto glass fiber filters, and the radioactivity was determined by liquid 
scintillation.  The extent of [3H]hypoxanthine incorporation was 
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untreated control cultures. The ICs0 value _+ SEM was calculated 
for each drug according to Desjardins et al. (40). 
Statistical Analysis 
Each experimental point was performed in duplicate or tripli- 
cate (per experiment), and all data are given as mean values + SEM. 
Statistical analysis was carried out using  the Student's  t test for 
unpaired  data. 
Resuks 
Characterization of NOS Activity in IRBC 
Enzyme Activity and Kinetics.  NOS activity was measured 
in the cell lysates of both normal human RBC and ring or 
trophozoite IILBC (FCK-3 strain).  In RBC (n  =  7), NOS 
activity was undetectable, whereas, in both ring and tropho- 
zoite IRBC, NOS activity was remarkable. IRBC NOS ac- 
tivity  exhibited  a  substrate  dependence  that  followed  a 
Michaelis-Menten pattern (Fig.  1). In ring IRBC (n  =  5), 
maximal rate (Vmax) was 444.4  +  120 pmol citrulline/min 
per 107 lysed parasites,  and half-maximal activity was detect- 
able at 1.37  _+ 0.3/~M t-arginine. In trophozoite IRBC (n  = 
6), the Vmax was 190.9  _+ 49.5 pmol citrulline/min per 107 
lysed parasites,  and Kr,  =  3.8  +_  0.8 #M L-arginine.  Vmax 
values were not significantly different in the two IRBC popu- 
lations,  whereas K,, for t-arginine  was significantly higher 
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Figure  1.  L-Arginine dependence of NOS  activity in lysates of ring 
IRBC (n  =  5; top) and trophozoite IRBC (n  =  6; bottom).  Each point 
represents mean values  -+  SEM; the curves are ideal plots obtained with 
the Michaelis-Menten equation:  Y  =  (X  x  Vmax)/(X  +  K~,), where 
X  =  L-arginine concentration (0.4/zM L-[3H]arginine +  1-100/zM t-argi- 
nine),  and Vmax and K~, are the values obtained for each cell type by 
Lineweaver-Burk transformation. 
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was much higher than in HUVEC: Vmax in HUVEC was 
18  _+  3.4 pmol citrulline produced/min per 107 lysed cells 
(n  =  4). To exclude the presence of arginase activity, 50 mM 
t-valine (41) was added to the reaction mixture, and no change 
of the radioactivity in the column eluate was detected, sug- 
gesting that arginase activity was virtually absent in IRBC. 
The presence of other urea cycle-related enzymes was ruled 
out,  since,  after  addition  of 2  #Ci  [14C]ornithine  to  the 
IRBC lysates, no 14C-labeled substance eluted in the fraction 
corresponding to citrulline.  An alternative source of citrul- 
line in living systems is arginine deiminase, an enzyme con- 
verting I:arginine into t-citrulline and ammonia. Its activity 
is detectable in bacteria but not in mammalian cells (9). The 
existence of such an enzyme in IRBC was ruled out, as for- 
mamidine, a known inhibitor of arginine deiminase (34), did 
not influence arginine conversion even at 1-mM concentra- 
tion. Moreover N-benzoylarginine ethylester (1 mM), a sub- 
strate  for  arginine  deiminase  (34),  did not  compete with 
[3H]arginine.  Since malaria  cultures  were run  with whole 
human blood, NOS activity could possibly stem from acti- 
vated leukocytes present in malaria cultures. This possibility 
was ruled out, since cultures prepared with washed P,.BC or 
with buffy coat-enriched RBC gave the same results (data 
not shown). Trophozoite IRBC suspensions (20-30% para- 
sitemia,  FCR-3 strain) were permeabilized by Sendal virus 
treatment  as described in Materials and Methods and then 
centrifuged  at  2,200 g  for 5 min.  NOS activity was mea- 
sured (n  =  3) both in  the pellet fraction  (134.08  _+  6.98 
pmol/min per 107 parasites) and in the supernatant  (5.6  + 
0.46 pmol/min  per  107 parasites).  As total  activity in the 
whole lysate was 139.96  _+  6.52 pmol/min per 107 parasites, 
the erythrocyte cytosolic compartment contained only m4% 
of IRBC NOS activity, and such activity is likely to be released 
from the small amount of parasites  that are damaged during 
Sendal virus treatment.  NOS activity did not differ signifi- 
cantly when measured in  RBC lysates freshly prepared or 
stored for 24-72 h at -  80~  or in liquid nitrogen. To clarify 
whether such a high NOS activity was a feature of FCR-3 
strain only, we checked enzyme activity in RBC infected with 
other strains of P.fakiparum (Table 1). NOS activity was clearly 
detectable in all strains of P..fakiparum investigated. To ascer- 
tain whether  NOS activity could be a common feature of 
Plasmodium parasites, we looked for its presence in Swiss mu- 
rine  RBC infected with  10 different  strains  of plasmodia: 
P. yoelii nigeriensis  (NIG strain), P. yoelii killicki (194 ZZK strain), 
P. yoelii yoelii (265 BY and 17 X strains), P. vincleeipetteri (279 
BY strain), P. vincleei vinckei (67 strain), P. chabaudi chabaudi 
(864 VD strain), P. chabaudi adami (887 KA strain), P. berghei 
(ANKA strain), and P. berghei (NK 65 strain). NOS activity 
was not detectable in  any of the RBC lysates obtained by 
infected or control mice (n  =  3 for each condition). On in- 
fection with P. berghei ANKA,  mice of susceptible strains 
such as CBA/Ca (42) and C57BL/6 (43) are known to de- 
velop a neurological syndrome, including seizures and coma, 
that is lethal in all untreated cases. IRBC from CBA/Ca (n  = 
3) and C57BL/6 (n =  3) strains infected with P. berghei  ANKA 
did not  show any NOS  activity. 
Enzyme  Features.  NOS  activity  in P. fakiparum  IRBC Table 1,  Nos Activity in Different Strains of P. falcipaura 
Strain  NOS=activity  *  n 
pmol/min  per 107 parasites* 
FCR-3  154.3  _+  12.05 II  4 
D2  117.47  _+  26.19  4 
D6  124.74  _+  29.9  4 
W2  99.1  _+  13.3  4 
HB3  106.4  _+  2.4  4 
*Enzyme activity was measured in cell lysates as described in Materials 
and Methods,  in the presence of 0.4 #M [3H]arginine alone. 
t Parasitemias were,  in each experiment,  15-20%  trophozoites. 
II Means  _+  SEM. 
(FCR-3  strain)  appeared  to be Ca++/calmodulin indepen- 
dent, as it was not modified in the presence of EDTA (1 mM) 
and the calmodulin inhibitors trifluoperazine (0.1 mM) and 
W5 (0.1 raM).  D-arginine,  up to 1 mM, did not compete 
with t-[3H]arginine,  indicating that IRBC NOS was stereo- 
specific. The NOS activity was maintained after having filtered 
the lysate through a filter (Ultraspin; Cambio, Milano, Italy) 
with a cut-off at 100,000 daltons, whereas it was completely 
abolished when the lysate passed through an Ultraspin filter 
with a cut-off at 50,000 daltons; in the latter case the activity 
was completely recovered in the filter. To determine whether 
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Figure 3.  Dose-response  curve of NOS activity in the lysate of ring 
IILBC (top) and trophozoite IILBC (bottom)  in the presence  of  three different 
NOS inhibitors. Measurement of enzymatic activity was performed as in- 
dicated in Materials and Methods  in the presence of 2.5/~Ci (0.4/~M) 
t-[3H]arginine. Enzyme activity is expressed as percentage of NOS activity 
(assumed to be 100% in the absence of inhibitors).  Each point represents 
the mean value _+ SEM of  four different experiments performed in duplicate. 
found in mammalian cells, as macrophages (iNOS)  or en- 
dothelial cells (eNOS), we carried out Western blot analysis 
of total cellular proteins by using mAbs anti-routine macro- 
phage iNOS and anti-human eNOS. Fig. 2 shows that IRBC, 
but not RBC, express a 97-kD protein recognized by both 
Figure 2.  Western blot analysis 
of." whole-ceU  lysates  from control 
(P,  BC) and P. faki~rum  I1LBC, 
and pellets obtained by treating 
RBC  and  IILBC  with  Sendal 
virus.  Experiments  were  per- 
formed with mAbs anti-routine 
macrophage  iNOS  (A)  and 
anti-human  endothelial  cNOS 
(B). Standard lysates from routine 
macrophage and human endothel- 
ium, respectively, were  used  as 
positive controls.  Representative 
blots  of three  different  experi- 
ments giving similar results are 
shown. 
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Figure 4.  Effect  of L-canavanine  on the growth of P. fakipamm strains 
in culture. Cultures at the ring stage (1% hematocrit,  2% parasitemia) 
were exposed to increasing concentrations of canavanine for 24 h. Then 
[3H]hypoxanthine  was added, and cells were harvested 24 h later. The cell- 
associated radioactivity was determined  and assumed as 100% viability. 
FCR-3 (closed  circles), ICs0 =  0.74  _+ 0.06 mM; W2 (open  circles), ICs0 
0.76  _+ 0.11 mM; D6 (closed  triangles) ICs0 =  0.7 +_ 0.029 raM. Results 
are from three different experiments. 
681  Nitric Oxide Synthase Activity in Plasmodiura  fakiparura anti-iNOS  and anti-eNOS  antibodies;  other bands,  corre- 
sponding to molecular masses of 85-70 kD, were less evi- 
dent. Such results agree with ultrafaltration  results,  indicating 
that NOS activity is associated with protein(s) having an ap- 
parent  molecular mass between 50 and  100 kD. 
Enzyme Inhibition.  P. falciparum IRBC  (FCR-3  strain) 
NOS activity was differently inhibited by three NOS inhibi- 
tots, L-canavanine, L-NAA, and L-NNA (Fig.  3). ICs0 values 
in ring IRBC (n  =  4) and trophozoite IRBC (n  =  4) were 
0.07 and 0.08 mM (t-canavanine),  1.29 and 0.39 mM (L-NAA), 
,,05 and 3.5  mM (t-NNA),  respectively. 
Effect of NOS Inhibitors on the Growth of Parasites.  RBC 
infected with different strains of P.fakiparum at the ring stage 
(1% hematocrit,  2%  parasitemia)  were incubated for 24 h 
with increasing concentrations of L-canavanine, the most effec- 
tive NOS inhibitor  in vitro.  [3H]Hypoxanthine incorpora- 
tion by IRBC, measured as a viability index, was inhibited 
in a dose-dependent way (Fig. 4), suggesting that NO produc- 
tion is relevant for the parasite.  When t-NNA was used as 
inhibitor,  parasite growth inhibition  was lower than  with 
L-canavanine, thus parallding  the different relative effects of 
the two compounds on NOS activity.  ICs0 values for L-NNA 
were as follows (means  _+  SEM): FCR-3, 5.25  _+  0.15 mM 
(n  =  3); W2, 4.07  _  0.13 mM (n  =  3);  and D6,  1.91  _+ 
0.13 mM (n  =  3). On the other hand, the addition of exoge- 
nous NO,  as SNP, was also toxic for IRBC cultures.  The 
actual ICs0 value for SNP was 9.33  _+ 0.45  x  10 -y M (n  = 
3; FCR-3 strain),  thus confirming previous results concerning 
inhibitory effect of SNP and other NO donors on intraerythro- 
cytic stages ofP. falciparum (44). It has already been demon- 
strated that the toxic effect of SNP is not attributable to fer- 
ricyanide moiety but rather to its NO-releasing property (44). 
Evidences of NO Production in Intact Cells 
Nitrite and Nitrate Production.  Nitrite measurement per- 
formed with  the  Griess  reagent  did  not  show NO2-  ac- 
cumulation in the culture medium of both human RBC (n  = 
6) and IRBC suspensions (n  =  9) after 2-72 h incubation. 
This negative result was not surprising, since it is well known 
that hemoglobin is a powerful NO scavenger and prevents 
nitrite formation. On the other hand, NO is known to react 
rapidly with oxyhemoglobin to give nitrate and methemoglo- 
bin (45).  RBC did not produce nitrate in the extracellular 
medium (n  =  3), whereas, in IRBC, net nitrate production 
in the supernatant was 7.4  _+  1.55 nmol/24 h per 107 para- 
sites (n  =  3), and incubation with2 mM L-canavanine inhib- 
ited nitrate  production  by 59%. 
Citrulline Synthesis (Short-term Incubation).  To detect NO 
synthesis  in  short  periods  of time,  we measured  [3H]cit- 
rulline production  after cell incubation with  [3H]arginine. 
Within  15 min, [3H]citrulline accumulation was not detect- 
able in the supernatant of human RBC, whereas,  in falciparum 
IRBC (FCR-3 strain),  it was dearly present,  both in ring 
(n  =  6) and trophozoite IRBC (n  =  7) (Fig. 5). [3H]Citrul- 
line production was significantly  higher (P =  0.02) in tropho- 
zoite  IRBC  than  in  ring  IRBC.  t-Canavanine  inhibited 
[3H]citrulline  synthesis  in  a dose-dependent  way (Fig.  5). 
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[3H]Citrulline synthesis by ring IRBC (n  =  6) and tropho- 
zoite IRBC (n = 7) in the absence (0 mM) or in presence of t-canavanine 
(0.1 and 1 mM). [3H]CitruUine  production was measured in the ottracel- 
lular medium after 15 min of incubation with [3H]arginine (see Materials 
and Methods). Data are means  _+  SEM of experiments performed in 
duplicate. 
The calcium ionophore ionomycin (2/~M) did not influence 
the [3H]citrulline production in either RBC or IRBC, thus 
suggesting that NOS activity was not dependent on the in- 
crease of intracellular Ca + +. A cell-associated [3H]citruUine 
formation  was  detectable  in  IRBC  (Fig.  5),  but,  unlike 
HUVEC (35),  most synthesized [3H]citruUine  was extracel- 
lular (data not shown).  This phenomenon could be attrib- 
uted to a very fast extrusion of citrulline by IRBC. If IRBC 
contained pathways to reconvert citruUine into arginine,  as 
the urea cycle in hepatocytes and the arginine-citrulline cycle 
in endothelial cells (46), this could induce an underestima- 
tion of NO synthesis in intact cells.  To clarify this point, 
IRBC were incubated with "cold" citrulline (1 mM) together 
with L-[3H]arginine.  No dilution  of [3H]citrulline was ob- 
served in these conditions (data not shown), thus suggesting 
that citrulline is not transformed into arginine by the IRBC. 
Citrulline Synthesis (Long-term Incubation).  After 24 h of 
incubation in culture medium,  citruUine,  measured colori- 
metrically,  was not detectable in human  RBC supernatant 
(n  =  4) but was dearly measurable in P. fakiparum  IRBC 
(FCR-3 strain) supernatant.  In ring IRBC, citrulline produc- 
tion was 1.55  _+  0.41 nmol/24 h per 107 parasites (n  =  3), 
and in trophozoite IRBC it was 1.49  _+ 0.14 nmol/24 h per 
107 parasites (n  =  5). Citrulline production was dependent 
on  substrate  availability,  since  added  arginase  (2  U/ml 
throughout the incubation period) inhibited citrulline  accumu- 
lation by 69  _  4% (n  =  3). Colorimetric detection recog- 
nizes the presence of the ureido group in citrulline;  these results 
allowed us to exclude that the radioactivity detected in the 
citrulline fraction of chromatography could be attributed to 
arginine  derivatives (i.e.,  argininic  acid, produced by some 
bacteria) having an isodectric point similar to that of citrulline. 
cGMP Content.  cGMP intracellular level in HUVEC is 
strictly related to endogenous NO production (35, 47). To 
look for an NO-sensitive guanylate cydase in normal and in- 
fected  human  RBC,  we  measured  the  basal  and  SNP- 
stimulated synthesis of cGMP in RBC and trophozoite IRBC 
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Figure 6.  L-Arginine  dependence of NOS activity in lysates  of HUVEC 
incubated for 24 h with supematant from RBC suspensions (A; n  =  3) 
and trophozoite  IKBC cultures (B; n  =  3). Each point represents mean 
values _+ SEM; the curves  were generated as described  in the legend to Fig. 1. 
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Figure 7.  Time course of NOS activity induction  in HUVEC incubated 
with RBC- or IRBC-conditioned medium. NOS activity was measured 
in the lysate of HUVEC incubated for the indicated time periods with 
conditioned medium from suspensions  of RBC (open  circles)  or IKBC (closed 
circles). Conditioned medium was fresh growth medium incubated for 
24 h with RBC or IKBC (10-20% parasitemia)  and then added to HUVEC 
cultures at a 1:1 (vol/vol) ratio with fresh medium 199 containing 20% 
FCS. After the indicated time periods, cells were washed and the measure- 
ment of enzymatic activity was performed as indicated in Materials and 
Methods,  in the presence of 2.5 #Ci (0.4 #M) L-[3H]arginine  and 1 #M 
L-arginine. Each point is a mean _+  SEM of three different experiments 
performed  in duplicate. 
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NOS activity in the tysate of HUVEC after 24 h of incuba- 
tion with IRBC-conditioned  medium at different conditions. Conditioned 
medium was diluted as indicated (1:5-1:80) with fresh growth medium, 
or supplemented with 10 #g/m1 cycloheximide (CHX) or 1 #M dexa- 
methasone (DMZ), or heated at 90~  for 5 min; then the modified condi- 
tioned medium was added at a 1:1 (vol/vol) ratio with fresh medium M-199 
containing 20% FCS. After 24 h of incubation (or only 6 h for CHX 
and respective  control), HUVEC were washed with PBS, lysed, and checked 
for NOS activity, as indicated in Materials and Methods, in the presence 
of 2.5  #Ci  (0.4  #M)  L-[~H]arginine. Conditioned medium was  fresh 
growth medium previously incubated for  24  h  with IILBC (10-20% 
parasitemia). Enzyme activity is expressed as percentage of NOS activity 
(assumed to be 100%  in HUVEC incubated  with nondiluted IRBC- 
conditioned medium). Each column is a mean +  SEM of three different 
experiments. 
(FCK-3 strain), cGMP levels in the two cell types were very 
low and not significantly different: 0.02  _+  0.01  pmol/107 
RBC (n  =  3) in RBC  and 0.03  _+  0.005  pmol/107 RBC 
(n  =  3) in trophozoite IRBC (100%  parasitemia). SNP (1 
mM) stimulation had no effect on cGMP levels in either cell 
type. Because of the high intracellular content of  hemoglobin, 
it  is difficult to  state whether the inefficacy of SNP is  at- 
tributable to the absence of a soluble, NO-sensitive guany- 
late cyclase or, more likely,  to the complete scavenging of 
exogenous NO by hemoglobin. 
Effect of  lRBC-conditioned Medium on NOS Activity in HUVEC 
Some pathogens are known to induce NOS activity in white 
ceUs (48, 49). Since high levels of NO were detected in malaria 
infections (21,  22),  it was plausible to assume that malarial 
parasites may also produce NOS-inducing factor(s). If so, the 
incubation of different cells with conditioned medium from 
falciparum IRBC cultures should lead to an increase of NOS 
Figure 9.  Detection  of  iNOS  and 
eNOS in HUVEC stimulated with KBC- 
and IRBC-conditioned  media. HUVEC 
were incubated  for  24  h  with growth 
medium (40%  vol/vol) from RBC and 
IILBC  suspensions.  On  the  whole 
HUVEC lysate, a Western blot analysis 
was performed with an mAb anti-mu- 
rine  macrophage  iNOS  and  mAb 
anti-human  eNOS,  respectively.  No 
difference  was observed  between HUVEC 
alone  and  KBC  medium-treated 
HUVEC (data not shown). Representa- 
tive  results  from  three  different  ex- 
periments. 
683  Nitric Oxide Synthase Activity in Plasmodium  fakiparum activity in target cells. HUVEC, chosen as target cells, were 
incubated for 24 h with trophozoite IRBC (FCR-3 strain)- 
conditioned medium; thereafter, the HUVEC monolayer was 
washed and NOt activity was measured in the lysate,  pre- 
pared as previously described, in the presence of 2.5/xCi 
(0.4 #M) t-[3H]arginine plus varying concentrations of cold 
t-arginine (1-100 gM). NOt maximal activity in HUVEC 
treated with supernatant from RBC was 3.6  _+  1.7 pmol 
citrulline/min per mg cell protein (n =  3), a value which did 
not differ from that found in control HUVEC (50). Enzyme 
maximal activity increased '~ 150-fold in HUVEC incubated 
with conditioned medium from trophozoite IRBC (547  _+ 
47  pmol  citruUine/min  per  mg  cell  protein,  n  =  3,  P 
<0.0001); Km did not significantly differ in the two condi- 
tions (10.1  +  1.5 gM arginine versus 10.6  _+ 4.7 gM argi- 
nine, respectively). Similar results were obtained with condi- 
tioned medium from W2 and D6 P. fakiparum strains (data 
not shown). NOt activity was Ca + + independent; the sub- 
strate dependence of the enzyme activity followed a typical 
Michaelis-Menten pattern (Fig. 6). The HUVEC enzyme ac- 
tivity was totally removed after ultrafiltration of the lysate 
with a filter with a cut-off of 100  kD;  NOS activity was 
completely recovered from the filters (data not shown). The 
increase in NOS activity in HUVEC was already detectable 
after 6 h of incubation and reached its maximum after 18-24 h 
(Fig.  7). In the presence of cycloheximide (10/~g/ml), NOS 
induction at 6 h was inhibited by 49.5  _+ 7.5% (n =  3) (Fig. 
8). After 24 h preincubation of HUVEC with 1/zM dexa- 
methasone (which is known to inhibit the increase of iNOS), 
the conditioned medium-induced NOS activity was inhibited 
by 92.5  _  3.5%  (n  =  3). The ability of the conditioned 
medium to induce NOt in HUVEC after 24 h incubation 
was still maintained after a 1:40 dilution of the conditioned 
medium with fresh medium (Fig. 8) but was completely abol- 
ished after heating at 60~  for 30 min or at 90~  for 5 min. 
The NOS-inducing activity was completely abolished when 
IRBC-conditioned medium was previously filtered through 
an Ultraspin filter with a 100-kD cut-off; the activity was 
completely recovered in the filters. Since IRBC cultures were 
performed in  whole blood,  it  was conceivable that  some 
cytokine(s) delivered from contaminating leukocytes activated 
by parasites might account for NOt-inducing activity of con- 
ditioned medium. This is not likely, since conditioned medium 
from both cultures prepared with washed RBC and cultures 
enriched with buffy coat showed the same ability to induce 
endothelial NOt (data not shown). NOt-inducing activity 
was not significantly different in the presence or absence of 
2.5-10 mM mannose, inositol-l-phosphate,  and phosphatidyli- 
nositol, alone or in any combination; these compounds are 
known to inhibit the effects of parasite-derived phospholipid 
exoantigens on target cells (51,  52). After 24 h  incubation 
of HUVEC with 20/zl packed IR.BC, an increase of NOS 
activity comparable to that obtained with the conditioned 
medium was measured; half of the same effect was obtained 
with the lysate of the same amount of IRBC (data not shown). 
No increase of NOS was detectable in HUVEC after incuba- 
tion with packed or lysed human normal RBC or RBC from 
malaria-infected mice. HUVEC were incubated for 24 h with 
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RBC- or IRBC (FCK-3)-conditioned medium, and their ly- 
sates were then tested for iNOS and eNOS proteins by Western 
blot analysis. IRBC medium-treated HUVEC showed an ap- 
parent increase of a 140-145-kD protein reacting with both 
eNOS and iNOt antibodies (Fig.  9). To evaluate the effect 
of conditioned medium on NO synthesis in intact HUVEC, 
we incubated endothelial cells (grown at confluence in 35- 
mm dishes) with RBC- and IRBC-conditioned medium for 
8 h, followed by 16 h of incubation with fresh medium. After 
this time, nitrite concentration in the supernatant was 1.65 
_+ 0.8 nmol/24 h per mg cell protein in RBC-conditioned 
HUVEC (n  =  4) and 26.52  _  4.3 nmol/24 h per mg cell 
protein in IRBC-conditioned HUVEC (n  =  4) (P <0.01). 
When short-term [3H]citrulline synthesis was performed in 
the same conditions, in KBC medium-treated HUVEC, in- 
tracellular synthesis was 0.057 +_ 0.01 pmol/min per mg cell 
protein (n  =  4) versus  0.293  +  0.036  (n  =  4) in IRBC 
medium-treated HUVEC  (P <0.002). 
Discussion. 
NO has been implicated in different aspects of P.fakiparum 
malaria infection (53).  The ability of cytokine-treated mac- 
rophages, neutrophils, and hepatocytes to kill plasmodia seems 
to correlate with their NO production (21, 22,  24,  25,  27, 
29), and NO derivatives inhibit the growth of P. fakiparum 
in vitro (23, 44). On the other hand, the neurological symp- 
toms in malaria patients have been attributed to increased 
plasma levels of TNF (18,  19). This cytokine is able to in- 
duce in many tissues  the synthesis of NO, which could be 
the real effector of cerebral malaria. TNF produced in response 
to malaria infection could induce NOS activity in endothelium, 
smooth muscle, and leukocytes (19).  NO might diffuse to 
the brain and damage its functions by acting in different ways. 
As a cytotoxic agent, it could cause lipoperoxidation and in- 
hibition of glycolysis and cell respiration (15, 17); neuronal 
death after ischemia and hypoglycemia has been attributed 
to an abnormal NO firing by nonadrenergic noncholinergic 
neurons (6). As a neurotransmitter (6), NO may disturb neu- 
ronal functions, and, as a vasodilator,  it can contribute to 
the increase of intracranial pressure and to systemic hypoten- 
sion observed in malaria patients (19). Until now, NO produc- 
tion in malaria infection has been thought to be the conse- 
quence of an increased secretion of cytokines by the host in 
response to the parasite (20,  22,  24,  25). 
In the present work, we demonstrate that Plasmodium it- 
self may generate NO and produce some soluble factor(s) able 
to evoke NO  synthesis in host tissues. 
NOS  activity,  measured  as  both  citrulline  and  nitrate 
production, is present in human RBC parasitized with P. fal- 
cipamm, is associated to the intraceUular parasite, and is present 
both in ring and trophozoite IRBC.  The enzyme content 
(which is related to Vmax) in the two blood stages is similar, 
whereas affinity for the substrate differs.  NOS activity is shared 
by any strain of P.fakiparum studied but is not a general prop- 
erty of Plasmodium IRBC,  as murine erythrocytes infected 
by 10 different strains of rodent parasites do not exhibit NOS activity. [3H]CitruUine synthesis in the P. falciparum IRBC 
lysate is attributable neither to urea cycle-rdated enzymes 
nor to an arginine deiminase, and it is impaired by NOS in- 
hibitors as L-canavanine, t-NAA, and L-NNA (Fig.  3). The 
parasite NOS is independent from Ca + + concentration in 
the reaction mixture and is not impaired by calmodulin in- 
hibitors, similar to the inducible isoform found in mammalian 
macrophages. L-Canavanine  is the most effective inhibitor, 
and it has been reported that this compound is relatively more 
specific for the inducible, Ca + +-independent NOS (12, 37). 
Indeed, t-canavanine is a weak inhibitor of HUVEC cNOS; 
ICs0 for I.-canavanine is  1.52  mM in HUVEC  (50)  versus 
0.07 and 0.08 mM in ring and trophozoite IRBC, respec- 
tively. The IRBC NOS has an apparent molecular mass lower 
than mammalian NOSs, and it is recognized by both anti- 
eNOS and anti-iNOS mAbs; thus, it is likely to belong to 
a new class of NO-synthesizing enzymes. 
NOS activity in the lysate cannot be equated to the actual 
NO production in intact cells. Its measurement is performed 
in a reaction mixture containing saturating concentrations 
(2 raM) of NADPH, which are much higher than those ob- 
served in intact RBC (about 30 #M) (54); moreover, cell dis- 
ruption may abolish any enzyme compartmentalization, which 
could limit the availability  of the substrate and/or cofactors. 
To gain information about the NO production in intact cells, 
it is advantageous to monitor the accumulation of nitrite or 
citrulline in the bathing medium after a 24-h incubation of 
IRBC  in  fresh culture medium;  furthermore,  short-term 
production of [3H]citrulline from [3H]arginine is the only 
way to check the NO production soon after a stimulus, and 
it allows the measurement of the Ca +  +-dependent compo- 
nent of NO synthesis in intact cells. Production of citrulline 
from arginine was observed in intact IRBC, but not in con- 
trol RBC, both with radiometric (Fig.  5) and colorimetric 
methods. CitruUine production was not modified by ionomy- 
cin, a calcium ionophore. It was inhibited by L-canavanine 
in a dose-dependent way and depended on availability  of ex- 
tracellular L-arginine, since pretreatment with arginase blocked 
its accumulation in the medium. The values of citrulline ac- 
cumulation after 24 h in IRBC cultures were markedly lower 
than those predictable from NOS activity in vitro. This sug- 
gests that the parasite enzyme operates normally at a rate 
that is a smaU fraction of its Vmax; such a restraint of the 
actual activity may be due to a limited availability  of sub- 
strate and/or cofactors. Alternatively, it is possible that most 
of the citrulline produced is promptly metabolized by the 
parasite, but our data from short-term radiometric measure- 
ments suggest that, to the contrary, citrulline is rapidly ex- 
truded from the IRBC.  Nitrite accumulation could not be 
detected in IRBC culture medium, most likely because of 
high levels of hemoglobin, a powerful NO scavenger, in IRBC. 
Oxyhemoglobin elicits conversion of NO into nitrate. When 
IRBC were incubated in a low nitrate culture medium, an 
accumulation of nitrate in the supernatant could be observed, 
and its amount was similar to extracellular citrulline produc- 
tion. However, RBC did not release nitrate as well as citrul- 
line in the supernatant. In HUVEC, NO production can be 
indirectly monitored by the cGMP intracellular levels (35, 
47). In human RBC, a synthesis of cGMP is measurable (54, 
55), although it is not clear whether a soluble guanylate cy- 
clase contributes to its synthesis. In RBC from mouse spleen, 
a membrane-associated guanyhte cychse, activated by lysophos- 
pholipids and fatty acids, has been detected (56).  cGMP has 
been found in virtually all cell types and phyla examined (13). 
In plasmodia, the guanylate cyclase activity has not been ex- 
tensivdy studied, but cGMP is detectable and its increase seems 
to play a key role in exflagellation orB. berghei  and P..fakiparum 
(57).  Our results show that, in control RBC,  cGMP levels 
are very low and similar to reported values (55).  The same 
cGMP concentrations are found in IRBC,  and neither are 
influenced by SNP treatment. It is diflicult to state whether 
these negative results are due to the absence of an NO-sensitive 
guanylate cyclase in RBC and IRBC or to the hemoglobin- 
mediated scavenging of endogenous and exogenous NO. 
Our data are in agreement with reports showing NO syn- 
thesis in species phylogenetically distant from mammalian 
ones, suggesting a very ancient origin for NO production 
in the biological systems (58).  It is hard to say which could 
be the role of NO in Plasmodium, since it is conceivable that 
the vast majority of this free radical is scavenged by hemo- 
globin before it crosses the RBC membrane and reaches the 
extracellular environment.  It is  possible  that Plasmodium- 
derived NO exerts its action in the host during the exoerythro- 
cytic stage (sporozoite, merozoite), perhaps participating in 
the  mechanisms of cell invasion.  However,  since parasite 
growth is inhibited by the NOS inhibitors I.-canavanine and 
L-NNA, and the effect of these compounds seems to corre- 
late with their ability to inhibit Plasmodium NOS activity, 
a physiological role for NO production should exist. At the 
present time, only speculations for such role can be made. 
NO could react with intraparasitic molecules, as pigment or 
￿9  thiols;  NO could participate in the assembly of free heine 
into hemozoin or favor the formation of S-nitrosothiols. It 
is well known that hemozoin accumulation is indispensable 
for parasite survival, as soluble heme can damage biological 
membranes and inhibit a variety of enzymes (59). Thus, the 
inhibition of parasite growth by L-canavanine may suggest 
that NO is necessary to heine detoxification. S-Nitrosothiols 
can store NO in a relatively stable form at acidic pH; it has 
been suggested that macrophages and other ceils could store 
S-nitrosothiols within the acidic lysosome environment, and 
after exocytosis these molecules spontaneously decompose by 
homolytic cleavage to NO and the corresponding disulfide 
(2).  The acidic milieu of the food vacuole in P. falciparum, 
could store as well part of NO as nitrosothiols, allowing the 
parasite to release NO in a second step. This could be of great 
importance for the cytotoxic effect exerted by the ingested 
IRBC on phagocytosing macrophages (60). 
We explored the possibility that P. falciparum IRBC may 
release a soluble factor able to induce NOS in host ceUs. In- 
deed, incubation with conditioned medium from trophozoite 
IRBC (FCR-3 strain) induces in HUVEC a 150-fold stimu- 
lation of NOS activity in a dose- and time-dependent way 
(Fig.  6).  Such an effect could be reproduced also with the 
conditioned medium from human RBC infected with other 
strains ofP. fakiparum., In parallel, both nitrite and citrulline 
685  Nitric Oxide Synthase Activity in Plasmodium  fakiparum synthesis by intact HUVEC were significantly increased in 
cells  incubated with  IRBC-conditioned  medium (FCR-3 
strain). The increase of NOS activity was at least partly at- 
tributable to de novo enzyme synthesis, as suggested by the 
time dependence of such an increase, the sensitivity to cyclo- 
heximide and dexamethasone, the higher Vmax value, and 
the increased level of a 140-145-kD protein reacting in the 
Western blot  with  anti-eNOS  and anti-iNOS  antibodies. 
These results suggest that IRBC-conditioned medium in- 
duces both the eNOS and iNOS isoforms in HUVEC; the 
induced activity was not attributable to an IRBC-like NOS, 
since it showed an apparent molecular mass >100 kD, as ex- 
pected for a mammalian NOS. The active factor in this con- 
ditioned medium showed a high molecular mass (>100 kD) 
and was thermolabile, suggesting that it is a protein or a gly- 
coprotein. We suggest naming this factor Plasmodium-derived 
NOS-inducing factor (PNIF). 
It has been demonstrated that human and rodent malaria 
parasites release exoantigens (61), which stimulate macrophages 
to produce reactive nitrogen intermediates (62)  and to se- 
crete TNF in vitro (63). The macrophage-activating compo- 
nent of such exoantigens seems to be a phospholipid (64). 
A glycosylphosphatidylinositol  toxin purified from P.J~kiparum 
induces TNF and II.-1 production by macrophages and regu- 
lates glucose and lipid metabolism in adipocytes (52). Phos- 
phatidylinositol  and inositolmonophosphate have been demon- 
strated to possess an inhibitory effect on exoantigen-induced 
production of TNF by murine macrophages (51); mannose 
and inositolmonophosphate inhibit the lipogenesis and the 
glucose oxidation evoked by glycosylphosphatidylinositol in 
adipocytes (52).  Our preliminary data seem to rule out the 
possibility that PNIF is a phospholipid exoantigen, because 
its NOS-inducing activity in HUVEC is not impaired by 
the presence of high concentrations of phosphatidylinositol, 
inositolmonophosphate,  or mannose. On the other hand, 
PNIF is unlikely to be an LPS-like  molecule or a cytokine 
such as II.-1, I1.-6, TNF, oncostatin M, IFN-% or GM-CSF; 
in fact, NOS induction in HUVEC is not triggered by any 
of these substances,  alone or in different combinations (un- 
published data). This suggests that PNIF cannot be identified 
with one or more of these cytokines. A not yet well-defined 
NOS-inducing activity is released by different cells in the cul- 
ture medium: rat colon carcinoma cells (49), PlHTR tumor 
cells (48),  and murine endothdioma calls (50). 
In conclusion, our results suggest that,  during malarial 
infections, the increase of NO production, which has been 
invoked in the pathogenesis of neurological and cardiovas- 
cular complications of the disease, may not need the inter- 
vention of host-derived cytokines. P. faki~rum IRBC release 
into the extraceUular environment a soluble factor able to 
induce NOS activity in the host calls and in the parasite it- 
self. A protracted activation of NOS in HUVEC could sup- 
port the persistent hypotension and neurological damages ob- 
served in malaria patients (6,  19). 
Our efforts are presently addressed to purifying both NOS 
and PNIF molecules from the P.falcilmrum-infected  erythro- 
cytes and to verifying whether their activity is detectable in 
other human and murine Plasmodium species, by extending 
our observations to malaria patients and murine models of 
cerebral malaria. 
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